SVP Head of Research, Co-founder
Sionna Therapeutics
Greg Hurlbut, PhD
Co-Founder and Senior Vice President, Discovery Research
Greg is co-founder of Sionna and serves as Senior Vice President of Discovery Research. Formerly, he was the Head of Protein Conformational Diseases and Rare Pulmonary Diseases Research groups at Sanofi Genzyme. He was the Principal Investigator for $32 million in grant funding from the Cystic Fibrosis Foundation Therapeutics Development Initiative to support CF drug discovery and preclinical development. Greg previously served as an adjunct faculty member in the Department of Biochemistry and Molecular Pharmacology at the University of Massachusetts Medical School. Greg received his Ph.D. in cell and molecular biology from Université Paris XI (Paris-Saclay), where he graduated summa cum laude for research performed at Massachusetts General Hospital and Harvard Medical School. Greg received a B.S. in biology from the University of Massachusetts, Amherst.